HIV gp120: Double lock strategy foils host defences

Structure

Volumn 6, Issue 8, 1998, Pages 945-949

  Sattentau, Quentin J ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032529071     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(98)00096-3     Document Type: Article

References (27)

1. Berger, E.A. (1997). HIV entry and tropism: the chemokine receptor connection. AIDS 11, S3-S16.
2. Berger, E.A., et al., & Weiss, R.A. (1997). HIV-1 phenotypes classified by co-receptor usage. Nature 391, 240.
3. Moore, J.P., McKeating, J.A., Huang, Y., Ashkenazi, A. & Ho, D.D. (1992). Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralisation differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66, 235-243.
4. Fouts, T.R., Binley, J.M., Trkola, A., Robinson, J.E. & Moore, J.P. (1997). Neutralization of the human immunodeficiency virus type 1 primary isolate JRFL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71, 2779-2785.
5. Sattentau, Q.J. & Moore, J.P. (1991). Conformational changes induced in the human immunodeficiency virus envelope glycoproteins by soluble CD4 binding. J. Exp. Med. 174, 407-415.
6. Thali, M., et al., & Sodroski, J. (1993). Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67, 3978-3988.
7. Rizzuto, C.D., et al., & Sodroski, J. (1998). A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949-1953.
8. Trkola, A., et al., & Moore, J.P. (1996). CD4-dependent, antibody sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187.
9. Wu, L., et al., & Sodroski, J. (1996). CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183.
10. Binley, J. & Moore, J.P. (1997). The viral mousetrap. Nature 387, 346-348.
11. Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J. & Wiley, D.C. (1997). Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430.
12. Chan, D.C., Fass, D., Berger, J.M. & Kim, P.S. (1997). Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273.
13. Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J. & Hendrickson, W.A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
14. Pollard, S.R., Rosa, M.D., Rosa, J.J. & Wiley, D.C. (1992). Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J. 11, 585-591.
15. Wyatt, R. (1993). Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of major variable regions. J. Virol. 67, 4557-4565.
16. Wyatt, R., et al., & Sodroski, J.G. (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711.
17. Sattentau, Q.J., Moore, J.P., Vignaux, F., Traincard, F. & Poignard, P. (1993). Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67, 7383-7393.
18. Poignard, P., Klasse, P.J. & Sattentau, Q.J. (1996). Neutralization of the human immunodeficiency virus type 1. Immunology Today 17, 239-246.
19. Moore, J.P., McKeating, J.A., Weiss, R.A. & Sattentau, Q.J. (1990). Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139-1142.
20. Moore, J.P., McKeating, J.A., Norton, W.A. & Sattentau, Q.J. (1991). Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralisation by soluble CD4. J. Virol. 65, 1133-1140.
21. Wu, H., Kwong, P.D. & Hendrickson, W.A. (1997). Dimeric association and segmental variability in the structure of human CD4. Nature 387, 527-530.
22. Parren, P.W.H.I., Sattentau, Q.J. & Burton, D.R. (1997). HIV-1 antibody-debris or virion? Nat. Med. 3, 366-367.
23. Wyatt, R. & Sodroski, J. (1998). The HIV-1 envelope glycoproteins: fusogens, antigens and immunogens. Science 280, 1884-1888.
24. Burton, D.R., et al. (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
25. Trkola, A., et al., & Katinger, H. (1996). Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp 120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70, 1100-1108.
26. Poignard, P., Fouts, T., Naniche, D., Moore, J.P. & Sattentau, Q.J. (1996). Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation. J. Exp. Med. 183, 473-484.
27. Reitter, J.N., Means, R.E. & Desrosiers, R.C. (1998). A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4, 679-684.